(Q33486621)

27 July 2017

title

Propranolol plasma concentrations and plasmapheresis (English)

1 reference

27 July 2017

Propranolol Plasma Concentrations and Plasmapheresis (English)

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

12 May 2024

author name string

R. L. Talbert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7338197

12 May 2024

Y. Y. Wong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7338197

12 May 2024

D. B. Duncan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7338197

12 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7338197

12 May 2024

publication date

1 December 1981

1 reference

full work available at URL

27 July 2017

http://journals.sagepub.com/doi/pdf/10.1177/106002808101501215

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Drug Intelligence & Clinical Pharmacy

12 May 2024

published in

1 reference

27 July 2017

volume

15

1 reference

27 July 2017

issue

12

1 reference

27 July 2017

page(s)

993-996

1 reference

Pharmacokinetics of propranolol in normal healthy volunteers

27 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Clinical Pharmacokinetics of Propranolol

12 May 2024

2

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment

12 May 2024

3

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Pharmacodynamics of Propranolol in Renal Failure

12 May 2024

4

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Hemolytic-uremic syndrome

12 May 2024

5

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Haemolytic uraemic syndrome in women taking oral contraceptives

12 May 2024

9

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-1973

12 May 2024

11

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Recurrent post-partum haemolytic uraemic syndrome

12 May 2024

12

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Antihypertensive effect of plasma exchange

12 May 2024

14

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Variable binding of propranolol in human serum

12 May 2024

15

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α1Acid Glycoprotein

12 May 2024

16

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling

12 May 2024

17

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

Research Communications in Chemical Pathology and Pharmacology

12 May 2024

18

27

419

Wilber B

1980

1 reference

https://api.crossref.org/works/10.1177/106002808101501215

12 May 2024

Identifiers

0 references

1 reference